1. Academic Validation
  2. LZTR1 is a melanoma oncogene that promotes invasion and suppresses apoptosis

LZTR1 is a melanoma oncogene that promotes invasion and suppresses apoptosis

  • Oncogene. 2025 Aug 30. doi: 10.1038/s41388-025-03538-2.
Antonella Bacchiocchi 1 2 Michael Mak 2 3 4 Zerin Mahzabin Khan 3 5 6 Xiangyu Gong 3 4 Mario Sznol 7 Zhenkun Na 8 9 Haomiao Su 8 Lok Hei Chan 10 Qin Yan 2 10 Dejian Zhao 11 Ryland D Mortlock 1 James Knight 11 Sarah A Slavoff 12 13 14 Ruth Halaban 15 16
Affiliations

Affiliations

  • 1 Department of Dermatology, Yale University School of Medicine, New Haven, CT, USA.
  • 2 Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA.
  • 3 Department of Biomedical Engineering, Yale University, New Haven, CT, USA.
  • 4 Department of Pharmacological Sciences, Stony Brook University, Stony Brook, NY, USA.
  • 5 Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Boston, MA, USA.
  • 6 Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.
  • 7 Department of Medicine, Yale Cancer Center, Yale University School of Medicine, New Haven, CT, USA.
  • 8 Department of Chemistry, Yale University, New Haven, CT, USA.
  • 9 Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou, China.
  • 10 Department of Pathology, Yale University School of Medicine, New Haven, CT, USA.
  • 11 Yale Center for Genome Analysis, Yale University, New Haven, CT, USA.
  • 12 Department of Chemistry, Yale University, New Haven, CT, USA. sarah.slavoff@yale.edu.
  • 13 Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, USA. sarah.slavoff@yale.edu.
  • 14 Institute for Biomolecular Design and Discovery, Yale University, West Haven, CT, USA. sarah.slavoff@yale.edu.
  • 15 Department of Dermatology, Yale University School of Medicine, New Haven, CT, USA. ruth.halaban@yale.edu.
  • 16 Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA. ruth.halaban@yale.edu.
Abstract

Leucine zipper like transcription regulator 1 (LZTR1) is amplified in acral melanomas, is required for melanocytes and melanoma cell proliferation, and it induces anchorage-independent growth, by yet unknown mechanisms. We therefore performed comprehensive studies to identify its activity in melanomas employing proximity biotinylation and co-immunoprecipitation combined with LC-MS/MS proteomics and molecular characterization. The results show that LZTR1 regulates the ubiquitin Proteasome system in melanoma cells and also associates with actin-related proteins and actin Cytoskeleton organization. Its downregulation suppresses the protective effect of the autophagy-initiating ULK1 and AMBRA1, regulators of normal cell survival and proliferation, and upregulates the sequestosome 1 (SQSTM1/p62), an autophagic cargo adapter which mediates selective degradation of ubiquitinated proteins. In contrast, overexpression of LZTR1 provides growth advantage under environmental stress, enhancing cell invasion, by activating ERBB3 receptor and its downstream targets Pyk2 and Src tyrosine kinases that regulate the Cytoskeleton, actin organization, cell spreading, cell migration and adhesion. LZTR1 is a "safeguard" for melanoma cells under stress and its downregulation can be exploited for melanoma therapy.

Figures
Products